Style | Citing Format |
---|---|
MLA | Mehri A, et al.. "Pyrimido[4,5-B]Indole Derivatives Bearing 1,2,4-Oxadiazole Moiety As Mdm2 Inhibitor Candidates in Cancer Treatment." Future Medicinal Chemistry, vol. 15, no. 6, 2023, pp. 517-532. |
APA | Mehri A, Mardanshahi M, Sirous H, Khanahmad H, Rostami M (2023). Pyrimido[4,5-B]Indole Derivatives Bearing 1,2,4-Oxadiazole Moiety As Mdm2 Inhibitor Candidates in Cancer Treatment. Future Medicinal Chemistry, 15(6), 517-532. |
Chicago | Mehri A, Mardanshahi M, Sirous H, Khanahmad H, Rostami M. "Pyrimido[4,5-B]Indole Derivatives Bearing 1,2,4-Oxadiazole Moiety As Mdm2 Inhibitor Candidates in Cancer Treatment." Future Medicinal Chemistry 15, no. 6 (2023): 517-532. |
Harvard | Mehri A et al. (2023) 'Pyrimido[4,5-B]Indole Derivatives Bearing 1,2,4-Oxadiazole Moiety As Mdm2 Inhibitor Candidates in Cancer Treatment', Future Medicinal Chemistry, 15(6), pp. 517-532. |
Vancouver | Mehri A, Mardanshahi M, Sirous H, Khanahmad H, Rostami M. Pyrimido[4,5-B]Indole Derivatives Bearing 1,2,4-Oxadiazole Moiety As Mdm2 Inhibitor Candidates in Cancer Treatment. Future Medicinal Chemistry. 2023;15(6):517-532. |
BibTex | @article{ author = {Mehri A and Mardanshahi M and Sirous H and Khanahmad H and Rostami M}, title = {Pyrimido[4,5-B]Indole Derivatives Bearing 1,2,4-Oxadiazole Moiety As Mdm2 Inhibitor Candidates in Cancer Treatment}, journal = {Future Medicinal Chemistry}, volume = {15}, number = {6}, pages = {517-532}, year = {2023} } |
RIS | TY - JOUR AU - Mehri A AU - Mardanshahi M AU - Sirous H AU - Khanahmad H AU - Rostami M TI - Pyrimido[4,5-B]Indole Derivatives Bearing 1,2,4-Oxadiazole Moiety As Mdm2 Inhibitor Candidates in Cancer Treatment JO - Future Medicinal Chemistry VL - 15 IS - 6 SP - 517 EP - 532 PY - 2023 ER - |